Dudediligence.

Alpha Cognition Inc. Common Stock

ACOGNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.9MMar ’25$1.7MJun ’25$2.8MSep ’25$2.8MDec ’25$3.5MMar ’26$6.1MJun ’26
Net income, by quarter
−$1.9MSep ’24−$5.8MDec ’24−$1.7MMar ’25−$10.5MJun ’25−$1.3MSep ’25−$6.9MDec ’25−$6.5MMar ’26−$8.8MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$10.2M
Gross profitnone on filenone on filenone on file$9.6M
Operating incomenone on file−$9.9M−$12.0M−$22.7M
Net incomenone on file−$13.8M−$14.8M−$20.7M
Operating cash flownone on file−$8.8M−$7.8M−$20.4M
Free cash flownone on filenone on file−$7.8M−$20.7M
Cash$2.1M$1.4M$48.5M$66.0M
Shares outstandingnone on file4.7M16.0M21.7M